| Financial Year |
March 31 2023 |
| Monetary Funds |
363,063,483.04 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
58,880,762.11 |
| Accounts Receivable |
1,025,802,208.67 |
| Advances to Suppliers |
84,682,523.55 |
| Other Receivables |
47,891,689.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,548,500.00 |
| Dividend Receivable |
-- |
| Inventories |
184,717,620.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,159,903.75 |
| Total Current Assets |
1,818,846,174.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
53,363,531.03 |
| Investment Properties |
-- |
| Fixed Assetes |
160,026,675.17 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
165,895,421.50 |
| R&D expenses |
10,128,411.80 |
| Goodwill |
445,042,686.21 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
64,610,906.68 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,050,913,875.76 |
| Total Assets |
2,869,760,049.91 |
| Short-Term Loans |
156,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,718,664.78 |
| Accounts Payable |
302,304,852.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,274,650.03 |
| Taxes Payable |
21,978,255.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,911,522.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,235,367.69 |
| Other Current Liabilities |
37,991,954.09 |
| Sub-Total of Current Liabilities |
612,030,816.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,632,952.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,753,640.92 |
| Total Liabilities |
639,784,457.31 |
| Paid-In Capital(Or Share Stock) |
593,718,564.00 |
| Capital Surplus |
711,563,601.17 |
| Surplus Reserve |
77,056,024.47 |
| LESS:Treasury Stock |
7,175,342.00 |
| Undistributed Profits |
880,939,016.37 |
| Minority Stockholder's Interest |
3,852,496.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,226,123,095.80 |
| Owner's Equity（Stockholder's Equity） |
2,229,975,592.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,869,760,049.91 |
